Molmart Ltd. MANCHESTER


Founded in 2016, Molmart, classified under reg no. 10303155 is an active company. Currently registered at 103 Oxford House M1 7ED, Manchester the company has been in the business for eight years. Its financial year was closed on 31st July and its latest financial statement was filed on July 31, 2023. Since October 18, 2016 Molmart Ltd. is no longer carrying the name Mm Genomics.

The company has 2 directors, namely Savvas N., Markella M.. Of them, Markella M. has been with the company the longest, being appointed on 29 July 2016 and Savvas N. has been with the company for the least time - from 12 September 2018. As of 28 April 2024, there were 4 ex directors - Tabisam K., Efthymios B. and others listed below. There were no ex secretaries.

Molmart Ltd. Address / Contact

Office Address 103 Oxford House
Office Address2 Oxford Road
Town Manchester
Post code M1 7ED
Country of origin United Kingdom

Company Information / Profile

Registration Number 10303155
Date of Incorporation Fri, 29th Jul 2016
Industry Other human health activities
End of financial Year 31st July
Company age 8 years old
Account next due date Wed, 30th Apr 2025 (367 days left)
Account last made up date Mon, 31st Jul 2023
Next confirmation statement due date Sat, 16th Mar 2024 (2024-03-16)
Last confirmation statement dated Thu, 2nd Mar 2023

Company staff

Savvas N.

Position: Director

Appointed: 12 September 2018

Markella M.

Position: Director

Appointed: 29 July 2016

Tabisam K.

Position: Director

Appointed: 01 July 2021

Resigned: 07 August 2023

Efthymios B.

Position: Director

Appointed: 29 July 2016

Resigned: 01 July 2017

Charalampos K.

Position: Director

Appointed: 29 July 2016

Resigned: 03 May 2022

Panagiotis M.

Position: Director

Appointed: 29 July 2016

Resigned: 01 July 2017

People with significant control

The list of persons with significant control who own or control the company includes 2 names. As BizStats discovered, there is Markella M. This PSC has 75,01-100% voting rights and has 75,01-100% shares. The second one in the persons with significant control register is Charalampos K. This PSC owns 25-50% shares and has 25-50% voting rights.

Markella M.

Notified on 1 July 2017
Nature of control: 75,01-100% shares
75,01-100% voting rights

Charalampos K.

Notified on 1 July 2017
Ceased on 1 July 2021
Nature of control: 25-50% voting rights
25-50% shares

Company previous names

Mm Genomics October 18, 2016

Annual reports financial information

Profit & Loss
Accounts Information Date 2019-07-312020-07-312021-07-312022-07-312023-07-31
Balance Sheet
Current Assets69 58454 89995 23964 637963
Net Assets Liabilities 30 48419 415-18 895-110 052
Cash Bank On Hand58 95652 71594 98562 132 
Debtors10 6282 1842542 505 
Other Debtors10 6282 1842542 505 
Property Plant Equipment 1 547952638 
Other
Description Principal Activities    86 900
Accrued Liabilities Not Expressed Within Creditors Subtotal   9181 564
Average Number Employees During Period33441
Creditors7 21025 96250 00050 83161 049
Fixed Assets   6381 931
Net Current Assets Liabilities62 37428 93768 46331 298-60 086
Total Assets Less Current Liabilities62 37430 48469 41531 936-58 155
Number Shares Issued Fully Paid     
Other Creditors7 21025 96226 76030 418 
Par Value Share     
Profit Loss     
Accumulated Depreciation Impairment Property Plant Equipment 9691 5641 878 
Bank Borrowings Overdrafts  50 00050 831 
Increase From Depreciation Charge For Year Property Plant Equipment 969595314 
Other Taxation Social Security Payable   2 860 
Property Plant Equipment Gross Cost 2 5162 516  
Total Additions Including From Business Combinations Property Plant Equipment 2 516   
Trade Creditors Trade Payables  1661 

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Change to a person with significant control July 1, 2021
filed on: 20th, December 2023
Free Download (2 pages)

Company search